If you need proof that anti-aging drugs are going to be serious business, you only have to look at today’s purchase of Sirtris, a pharmaceutical company dedicated to researching the anti-aging benefits of restricted-calorie diets, by GlaxoSmithKline. The price of the purchase? $720 million. And they plan to make all of that money back and a whole lot more by selling you pills to make you live to 1